Skip to content

DAIR for Infected Total Hip Arthroplasty - Does the Operative Approach Influence the Functional Result?

Debridement, Antibiotics and Implant Retention (DAIR) for Infected Total Hip Arthroplasty- Does the Operative Approach Influence the Functional Result?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03161990
Enrollment
226
Registered
2017-05-22
Start date
2018-04-23
Completion date
2018-11-17
Last updated
2019-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty Complications, Hip Prosthesis Infection

Keywords

DAIR, Transgluteal approach, Posterior approach

Brief summary

The functional outcome and quality of life after treatment for an infected hip arthroplasty have been found to be significantly worse compared to an uncomplicated arthroplasty. However, the type of revision surgery chosen to treat the infection plays a role for the functional outcome. The concept of DAIR (debridement, antibiotics and implant retention) has been shown to yield god results with respect to infection control in cases of early infection with a stable implant and better functional results than a to-stage revision. In patients where infection control was achieved after just one DAIR procedure the functional outcome was comparable to an uncomplicated primary arthroplasty. However, it is not known if the operative approach used for the primary and revision surgery plays a role for the functional result after treatment of an infected total hip arthroplasty with DAIR. The project's aim is to investigate if the choice of the operative approach (transgluteal or posterior) for the primary hip replacement and the revision surgery has an influence on the functional result after debridement and implant retention for an infected total hip replacement.

Detailed description

Potential study participants will be identified in the Norwegian Arthroplasty Register. Patients who have been revised once for an infected total hip arthroplasty with debridement and implant retention and in whom either the transgluteal og posterior operative approach was used in both procedures will be selected. The potential participants will be contacted by letter. They will be asked for written informed consent and to fill out three questionnaires: the Hip Disability Osteoarthritis Score (HOOS), which also allows for the calculation of the Western Ontario and McMaster Universities osteoarthritis index (WOMAC), the EQ-5D (quality of life) and a questionnaire asking about confirmation that the patient only has been revised once for his/her infected arthroplasty, about limping, other complications (nerve injury, dislocation, reoperation for other causes than infection), if the infection is considered to have been eradicated and overall satisfaction. The data recorded in the Norwegian Arthroplasty Register will be used in a multiple linear regression analysis to evaluate if the surgical approach is an independent factor influencing the outcome measures.

Interventions

PROCEDURETransgluteal approach to the hip joint

Operative approach to the hip joint where the abductors are partly detached from the greater trochanter and the hip joint is approached through the anterior part of the capsule.

PROCEDUREPosterior approach to the hip joint

Operative approach to the hip joint where the short external rotators are detached from the greater trochanter and the hip joint is approached through the posterior part of the capsule.

Sponsors

Haukeland University Hospital
CollaboratorOTHER
University Hospital, Akershus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The infected total hip arthroplasty has only been revised once. * The revision procedure was a debridement and implant retention. * Both, the primary and the revision procedure were performed through the same surgical approach; either the transgluteal or the posterior approach.

Exclusion criteria

* No written informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Function subscale score of the WOMACAt minimum 1 year, on average 5 year follow-up from the DAIR procedureFunction subscale score of the Western Ontario and McMaster Universities osteoarthritis index (WOMAC)

Secondary

MeasureTime frameDescription
WOMAC scoreAt minimum 1 year, on average 5 year follow-up from the DAIR procedureWestern Ontario and McMaster Universities osteoarthritis index score
HOOSAt minimum 1 year, on average 5 year follow-up from the DAIR procedureHip Disability Osteoarthritis Score
EQ-5D scoreAt minimum 1 year, on average 5 year follow-up from the DAIR procedureQuality of life score
Other complicationsAt minimum 1 year, on average 5 year follow-up from the DAIR procedurePatient reported nerve injury, dislocation, reoperation for other causes than infection.
Overall satisfactionAt minimum 1 year, on average 5 year follow-up from the DAIR procedureOverall satisfaction with the revised total hip replacement assessed by questionnaire.
LimpingAt minimum 1 year, on average 5 year follow-up from the DAIR procedurePatient reported limping on the side of the revised total hip replacement.

Other

MeasureTime frameDescription
Infection eradicationAt minimum 1 year, on average 5 year follow-up from the DAIR procedurePatient reported eradication of the infection of their total hip arthroplasty.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026